Drug Safety

Momentum’s Drug Safety and Risk Strategy Exchange is taking place on July 30-31 at the American University Washington College in Washington, DC.

This time our 4th REMS Innovation Summit and the 3rd PV Oversight & Inspection Readiness Summit will be colocated to potentialize and promote engagement and networking and also for the first time, we are creating the PV & REMS INTERSECTION!

In this intersection, we will have half a day dedicated to topics of relevance and interest to both the PV and the REMS audiences with interactive sessions and case studies to maximize your time in attendance. Each event has its agenda with thought-provoking sessions and panel discussions while sharing networking opportunities.

Join us on July 30-31 and make sure to invite your PV/REMS peers!

Register Today

Jonathan Banchs

Senior Director of Content & Experience

MOMENTUM EVENTS

Testimonials

2024 Speaking

Faculty

Josue Bautista Arteaga

GCP/PV Auditor

NOVARTIS

Kal Elhoregy

Senior Director, Global Risk Management & Pharmacovigilance Compliance

AMNEAL PHARMACEUTICALS

Garry Flounders

Associate Director – Global Pharmacovigilance Operation Lead, Biosimilars

BIOGEN

Jacqueline Gerena

Director, Risk Management Strategy

JOHNSON & JOHNSON

Bill Haddock

Vice President of Pharmacovigilance and Quality

OVID THERAPEUTICS

Catina O’Leary

President & CEO

HEALTH LITERACY MEDIA

Maha Saad

Associate Vice President, Pharmacovigilance and REMS

BRAEBURN

Sameer Thapar

Adjunct Professor, Drug Safety & Pharmacovigilance

TEMPLE UNIVERSITY

Become a Speaker

Gold Sponsor

2024 SPONSORSHIP OPPORTUNITIES ARE OPEN

Sponsorship is a great way to enhance your brand’s visibility and help you connect with top-level decision-makers, innovators, and industry disruptors. There are a number of ways to maximize branding opportunities at the summit.

BECOME A SPONSOR

Top Reasons to Attend

Grow and foster the relationship between your REMS and your Drug Safety peers to help reduce burdens and secure a more effective oversight and REMS implementation

Discuss effective and compliant REMS and AI applications and explore all the options and possibilities

Participate in active engagement on how to successfully grade your 3rd party vendors

Understand the impact and growth from telehealth and telemedicine and how to accommodate in the REMS space compliantly

Document Safety and Adverse Events Reporting on REMS while being FDA compliant

Grow and foster the relationship between your REMS and your Drug Safety peers to help reduce burdens and secure a more effective oversight and REMS implementation

Examine a practical approach on how Real-world Evidence data should be applied in Drug Safety/PV

Discuss effective and compliant PV AI applications and explore all the options and possibilities

Participate in active engagement on how to successfully grade your 3rd party vendors

Recognize the value of PV systems to streamline communication and achieve inspection readiness

Who should attend?

This event is designed for pharmaceutical, biotech, and medical device professionals with responsibilities in the following areas:

Pharmacovigilance

Safety & Risk management
Drug safety
Technovigilance
PV Compliance
Safety Surveillance
Medical Affairs
Regulatory Affairs
Inspection and Audit
Post-market studies
Real-World Evidence Generation
Medical product safety assessment

Drug Research & Development
Clinical Pharmacology
Medical information
Health outcomes

REMS

Benefit/Risk Management
Medical Direction
Quality Assurance
Real-World Evidence Generation
Clinical Risk Management
Life Cycle Management
Regulatory Affairs/Legal/Compliance
Clinical Research
Clinical Risk Management Compliance
Epidemiology/Pharmacoepidemiology